stem cell research

To increase access to stem cells and their use, the federal government in 2005 created public banks, including at Mercy Medical Center and St. Agnes Hospital. The banks have seen success in the units of blood collected but have struggled financially with some banks closing.

Catonsville veterinarian taking part in national test of stem cell therapy to help arthritic dogs

In a study published last month in the journal Cell Reports, Kwon says he's discovered an answer in an unlikely place: newborn rats.

Researchers from Johns Hopkins University School of Medicine will join several other academic and industry scientists in developing a new, stem cell based method of assessing treatments for schizophrenia and bipolar disorder

Johns Hopkins neuroscientists and their partners in Florida and Atlanta have shown the Zika virus destroying or damaging cells that are the building blocks of brain development in the lab, another step toward confirming the Zika's connection to the birth defect microcephaly.

Vanna Belton can see again but no one is sure how, or even if, the stem cell treatment she underwent worked. Many studies are underway to show the value of stem cells but many scientists say proving they can repair organs and cure diseases is a ways off.

Researchers at the Johns Hopkins Bloomberg School of Public Health are growing tiny replicas of the human brain to help the study of neurological diseases in a trend many hope could lead to better treatments and even cures for some of the most debilitating illnesses.

Osiris Therapeutics has gotten some unwanted attention, from a series of shareholder lawsuits in the wake of an earnings restatement to web postings questioning sales and financial reports.

Researchers at Johns Hopkins have developed a method to successfully grow a type of eye cell in a lab, which could one day lead to a cure for blindness caused by glaucoma or multiple sclerosis.

A clinical trial through the University of Maryland Medical School and the University of Maryland Marlene and Stewart Greenebaum Cancer Center gave those with blood plasma cancer longer remission times by re-engineering parts of the immune system

Record competition, a new administration in Annapolis and looming budget cuts have research advocates uneasy about Maryland's stem cell research investment program.